Anbio Biotechnology NNNN

6.30 0.15 2.44% as of 25 Sep
Market cap
$884.9M
P/E
—

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Dec '23 Dec '24 Jun '25 Dec '25
Cash and Short Term Investments

+1 more quarter

9.69 11.76 13.43 11.90
Receivables
1.89 1.07 3.72 3.66
Other current assets
4.18 5.71 10.17 14.69
Total current assets
15.75 18.53 27.68 30.24
Goodwill and Intangible Assets (Total)
0.00 0.00 — 0.00
Long-term assets (Other)
0.06 0.39 — —
Total non-current assets
0.06 0.39 — —
Total Assets
15.81 18.92 27.68 30.24
Accounts Payable
0.83 1.63 0.06 —
Current Part of Capital Lease
0.00 0.00 — 0.00
Current Part of Taxes to Pay
0.00 0.00 — 0.00
Other current liabilities
0.17 0.11 0.07 0.09
Total current liabilities
0.99 1.73 0.13 0.09
Total liabilities
0.99 1.73 0.13 0.09
Additional Paid In Capital
0.00 0.00 6.56 6.56
Preferred Stock (Total)
0.00 0.00 — 0.00
Common Stock (Net)
0.01 0.01 0.01 0.01
Retained Earnings
14.80 17.17 20.97 23.58
Treasury Stock
0.00 0.00 — 0.00
Shareholders Equity (Other)
0.00 0.00 — 0.00
Common Equity (Total)
14.82 17.19 27.55 30.16
Shareholders Equity (Total)
14.82 17.19 27.55 30.16
Shareholders Equity and Liabilities (Total)
15.81 18.92 27.68 30.24
Shares (Common)
— — 143.89 —
Shareholders Equity (Tangible)
14.82 17.19 27.55 30.16
Net Debt
(9.69) (11.76) (13.43) (11.90)
Other line items
Non-current Revenue (Deferred)
0.00 0.00 — 0.00
Minority Interests
0.00 0.00 — 0.00

Fold the line items

In millions of $ except per-share values · columns are period end dates